Fort Washington Investment Advisors Inc. OH trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 16.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 790,420 shares of the company's stock after selling 152,880 shares during the period. Fort Washington Investment Advisors Inc. OH owned 0.48% of Option Care Health worth $27,625,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Option Care Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after purchasing an additional 75,313 shares in the last quarter. Wellington Management Group LLP grew its stake in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after acquiring an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares in the last quarter. Northern Trust Corp increased its stake in shares of Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after purchasing an additional 278,158 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Option Care Health during the 4th quarter worth about $60,219,000. Institutional investors and hedge funds own 98.05% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on OPCH. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.
Get Our Latest Research Report on OPCH
Option Care Health Stock Up 0.7%
Shares of OPCH traded up $0.22 during midday trading on Monday, reaching $31.82. 1,353,945 shares of the company were exchanged, compared to its average volume of 1,925,213. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The stock has a 50-day moving average price of $32.22 and a 200-day moving average price of $30.35. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.21 billion, a price-to-earnings ratio of 26.74, a P/E/G ratio of 2.30 and a beta of 0.74.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. During the same period last year, the business posted $0.26 earnings per share. Research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.